«PNEUMOCOCCUS»に関連する英語の本
以下の図書目録から
pneumococcusの使いかたを見つけましょう。
pneumococcusに関する本と英語文献で使われた文脈を提供するための簡単な抜粋文。
particularly fascinating topics covered in this volume include: comparative gram positive genomics; human and bacterial determinants of colonization versus invasive disease; gram positive interaction with innate immune response; traffic of ...
2
Pneumonia and
Pneumococcus Infections
This historic book may have numerous typos and missing text. Purchasers can download a free scanned copy of the original book (without typos) from the publisher. Not indexed. Not illustrated. 1904 Excerpt: .
Robert Bruce Preble, 2009
3
Clinical Infectious Disease
The pneumococcus is without question the most common cause of OPSI. This α-
hemolytic, polysaccharide-encapsulated, gram-positive coccoid bacterium has a
distinctive morphology on staining, a so-called lancet shape (Figure 95.4).
4
The Professor, the Institute, and DNA
Avery, O. T., and Heidelberger, M. Immunological relationships of cell
constituents of pneumococcus. Proc. Soc. Exp. Biol, and Med. 20:435.
Heidelberger, M., and Avery, O. T. The soluble specific substance of
pneumococcus. /. Exp. Med.
5
Bacterial Infections of Humans: Epidemiology and Control
Introduction The pneumococcus (Streptococcus pneumoniae) is a major cause of
pneumonia and meningitis worldwide. In his classic book entitled The Biology of
the Pneumococcus, published in 1938, Benjamin White*11 listed 19 different ...
Alfred S. Evans, Philip S. Brachman, 1998
6
Vaccines: What You Should Know
The pneumococcus vaccine is also made by combining a protein to a sugar. One
of the reasons that it has been hard to make a successful pneumococcal vaccine
is that ninety different strains of pneumococcus can cause disease. Fortunately ...
Paul A. Offit, Louis M. Bell, 2003
7
Vaccines and Your Child: Separating Fact from Fiction
pneumococcus Pneumococcus: tHe disease 70,000—that's the number of cases
of pneumonia caused by pneumococcus every year in the United States before a
vaccine for children was available. And pneumonia isn't the worst ofit.
Paul A. Offit, Charlotte A. Moser, 2011
8
The Prokaryotes: Vol. 4: Bacteria: Firmicutes, Cyanobacteria
Pneumococcus is a fragile body and contains within itself enzymatic forces that
lead to its disruption and disintegration, rob the substrate in which it lives of
nutrient substances, and from these substances evolve chemical agents that
arrest ...
Martin Dworkin, Stanley Falkow, 2006
9
Silent Victories : The History and Practice of Public Health ...
To produce an anti-pneumonia vaccine, Dubos experimented with ways to make
the pneumococcus into a better antigen. “What I did was work out a fairly practical
technique whereby the pneumococcus could be killed under conditions that ...
Epidemiology Program Center for Disease Control John W. Ward Director of the Office of Scientific Health and Communications, Christian Warren Professor of History New York Academy of Medicine, 2006
10
Schaechter's Mechanisms of Microbial Disease
Jeffrey N. Weiser Pneumococcus: Is an a-hemolytic streptococcus that commonly
colonizes the human nasopharynx. Is a frequent etiologic agent of respiratory
tract infections, including otitis media, sinusitis, chronic bronchitis, and
pneumonia, ...
Moselio Schaechter, N. Cary Engleberg, Victor J. DiRita, 2007
用語«PNEUMOCOCCUS»を含むニュース項目
国内外の報道機関が語った内容や、次のニュース項目の文脈から
pneumococcusという用語がどのように使われているかを調べてみましょう。
Genocea Biosciences Lifted to "Buy" at Zacks (GNCA)
... therapeutic candidate in HSV-2, GEN-003, as well as earlier-stage programs in Pneumococcus, Chlamydia, HSV-2 prophylaxis and Malaria. «WKRB News, 7月 15»
Peninsula vaccines spinout snags $22 million in early funding
Conjugate vaccines are an $8 billion market and are a safe way to attack pneumococcus and other bacteria responsible for flu, the deadly ... «San Francisco Business Times, 7月 15»
Zacks Upgrades Genocea Biosciences to Buy (GNCA)
... therapeutic candidate in HSV-2, GEN-003, as well as earlier-stage programs in Pneumococcus, Chlamydia, HSV-2 prophylaxis and Malaria. «Watch List News, 7月 15»
Genocea Biosciences Rating Increased to Buy at Zacks (GNCA)
... therapeutic candidate in HSV-2, GEN-003, as well as earlier-stage programs in Pneumococcus, Chlamydia, HSV-2 prophylaxis and Malaria. «Dakota Financial News, 7月 15»
WHO/UNICEF--Infant Immunization Coverage Increasing, But Not …
The study also takes into account how are used the vaccines against pneumococcus and rotavirus, and reports that only 19 percent of the ... «The Official Government News Portal of Sri Lanka, 7月 15»
Elderly's organization calls for vaccinating over-65's
KBO points to a study done by UMC Utrecht on the vaccination against pneumococcus – a bacteria that can cause pneumonia – that found that ... «NL Times, 7月 15»
WHO/UNICEF's Infant Immunization Coverage Increasing, But Not …
The study also takes into account how are used the vaccines against pneumococcus and rotavirus, and reports that only 19 percent of the ... «Radio Cadena Agramonte, 7月 15»
Research and Markets: World Streptococcus Pneumoniae …
Streptococcus Pneumoniae (Pneumococcus) Infections Pipeline Insights provides the in-depth analysis of the pipeline assets across the ... «Business Wire, 7月 15»
Puno to build health centers for areas affected by cold
From January to July this year, the Ministry of Health distributed vaccines against pneumococcus and influenza to more than 3 million residents. «Peru this Week, 7月 15»
GAVI honours Prez Mahama
... against pneumonia and diarrhoea (Pneumococcus and Rotavirus), meningitis, second dose measles and Injectable Polio vaccine (IPV). «Graphic Online, 7月 15»
